CLOS
ACHV icon

Compagnie Lombard Odier SCmA’s Achieve Life Sciences ACHV Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1
Closed -$1K – 720
2016
Q4 		$1K Hold
1
– – ﹤0.01% 796
2016
Q3 		$1K Hold
1
– – ﹤0.01% 891
2016
Q2 		$2K Hold
1
– – ﹤0.01% 880
2016
Q1 		$2K Hold
1
– – ﹤0.01% 945
2015
Q4 		$3K Buy
+1
New +$4.23K ﹤0.01% 905

Other funds holding ACHV

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Compagnie Lombard Odier SCmA's ACHV Position: Q1 2017 in Review

Compagnie Lombard Odier SCmA sold out of Achieve Life Sciences (ACHV) in Q1 2017, closing a stake of 1 share — an estimated $1K sold.

Compagnie Lombard Odier SCmA first reported a position in ACHV in Q4 2015 and held it in 5 quarters. The position peaked at $3K in Q4 2015. 26 funds tracked by Wall St. Rank hold ACHV as of Q1 2017.

  • Compagnie Lombard Odier SCmA reported no remaining Achieve Life Sciences position as of Q1 2017 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 1 Achieve Life Sciences share in Q1 2017, an estimated $1K.
  • Compagnie Lombard Odier SCmA first reported a position in Achieve Life Sciences in Q4 2015 and held it in 5 quarters.
  • Compagnie Lombard Odier SCmA's Achieve Life Sciences position peaked at $3K in Q4 2015.
  • 26 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2017.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2017, filed 15 May 2017.